IHE DELFT OPENCOURSEWARE

At Protheragen, we are dedicated to pushing the boundaries of the field by providing diagnostic and therapeutic drug development services for a range of rare blood diseases. Through extensive preclinical studies, we evaluate a diverse array of innovative therapies using in vitro and in vivo models to ensure both their effectiveness and safety. Our goal is to support our customers' research in rare blood diseases and work together to fight these challenging diseases.